Physician profile
Lon Weiner
NPI 1043310394
$622,261.20
in general payments reported to CMS, 2019-2025
14 companies · $2,917 in 2025
The $2,917 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131K · 2020: $70K · 2021: $92K · 2022: $268K · 2023: $49K · 2024: $9,393 · 2025: $2,917.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $61K · Food and Beverage: $391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $61,061.24 |
| Food and Beverage | $391.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medartis INC. | $327,886.61 | 2022-2025 | Aptus |
| Nextremity Solutions INC. | $273,255.40 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $19,954.48 | 2019-2023 | Compr Aug Mini Cptrd Pn Plcmnt Gd Lg (Sup), Gps III Platelet Concentration System |
| Globus Medical, INC. | $416.73 | 2021-2023 | Distal Tibia Plating, Ankle Fracture System |
| Depuy Synthes Sales INC. | $134.44 | 2022 | |
| Terumo Bct, INC. | $134.05 | 2020 | |
| Sanara Medtech INC. | $103.10 | 2024 | Celleraterx |
| Stryker Corporation | $96.33 | 2019-2020 | |
| Baxter Healthcare | $93.17 | 2019-2023 | Actifuse |
| Arteriocyte Medical Systems, INC. | $86.56 | 2019-2021 | |
| Acell, INC. | $40.71 | 2019 | |
| Bioventus LLC | $27.50 | 2019 | |
| Smith+Nephew, INC. | $16.64 | 2019 | |
| Ferring Pharmaceuticals INC. | $15.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,315,944.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lon Weiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.